Evaxion A (EVAX) Non-Current Assets (2019 - 2025)

Evaxion A (EVAX) reported Non-Current Assets of $3.5 million for Q4 2025, down 5.73% on a YoY basis from $3.7 million in Q4 2024, and down 17.91% quarter-over-quarter from $4.3 million in Q2 2025.

Evaxion A (EVAX) Non-Current Assets (2019 - 2025) Analysis & Trends

Evaxion A has reported Non-Current Assets for 7 years, with the latest figure at $3.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 5.73% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (down 5.73% YoY), and the FY2025 full-year result was $3.5 million, down 5.73% from the prior year.
  • Non-Current Assets for Q4 2025 stood at $3.5 million, down from $4.3 million in the prior quarter.
  • The five-year high for Non-Current Assets was $7.8 million in Q3 2021, with the low at $2.4 million in Q1 2021.
  • Historically, Non-Current Assets has averaged $4.8 million across 5 years, with a median of $4.5 million in 2023.
  • Annual changes were most pronounced in 2021 — Non-Current Assets jumped 437.73% — and 2024, when it retreated 18.04%.
  • Evaxion A's Non-Current Assets stood at $5.5 million in 2021, then declined by 7.66% to $5.0 million in 2022, then retreated by 9.94% to $4.5 million in 2023, then dropped by 18.04% to $3.7 million in 2024, then fell by 5.73% to $3.5 million in 2025.
  • The last three Non-Current Assets figures came in at $3.5 million (Q4 2025), $4.3 million (Q2 2025), and $3.7 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 22.66 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.51 Mn
Jun 30, 2025 4.27 Mn
Dec 31, 2024 3.72 Mn
Jun 30, 2024 4.53 Mn
Dec 31, 2023 4.54 Mn
Jun 30, 2023 5.39 Mn
Dec 31, 2022 5.04 Mn
Jun 30, 2022 5.48 Mn
Mar 31, 2022 5.70 Mn
Dec 31, 2021 5.46 Mn
Sep 30, 2021 7.80 Mn
Jun 30, 2021 4.23 Mn
Mar 31, 2021 2.43 Mn
Dec 31, 2020 1.02 Mn
Dec 31, 2019 126,000.00